BORTOLOTTI, MASSIMO
BORTOLOTTI, MASSIMO
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Assegnisti
(ClO4)2: Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity
2018 Toniolo, Gianluca; Louka, Maria; Menounou, Georgia; Fantoni, Nicolò Zuin; Mitrikas, George; Efthimiadou, Eleni K.; Masi, Annalisa; Bortolotti, Massimo; Polito, Letizia; Bolognesi, Andrea; Kellett, Andrew; Ferreri, Carla; Chatgilialoglu, Chryssostomos
A new potent and selective anti-lymphocytes-immunotoxin for the treatment of GVHD and lymphocyte-derived neoplasms
2009 Polito L.; Bortolotti M.; Pedrazzi M.; Farini V.; Bolognesi A.
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?
2022 Zanello A.; Bortolotti M.; Maiello S.; Bolognesi A.; Polito L.
Anti-tumor activity of Epratuzumab/saporin-S6.
2012 Bortolotti M.; Polito L; Farini V; Pedrazzi M; Battelli MG; Bolognesi A.
Antibody conjugates for sarcoma therapy: How far along are we?
2021 Polito L.; Calafato G.; Bortolotti M.; Chiarelli Olivari C.; Maiello S.; Bolognesi A.
Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1
2016 Polito, Letizia; Bortolotti, Massimo; Pedrazzi, Manuela; Mercatelli, Daniele; Battelli, Maria Giulia; Bolognesi, Andrea
ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells.
2009 Polito L.; Bortolotti M.; Farini V.; Pedrazzi M.; Tazzari P.L.; Bolognesi A.
Bouganin, an attractive weapon for immunotoxins
2018 bortolotti massimo; bolognesi andrea; polito letizia
CD38 as a target of IB4 mAb carrying saporin-S6: Design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia
2005 Bolognesi A.; Polito L.; Farini V.; Bortolotti M.; Tazzari P.L.; Ratta M.; Ravaioli A.; Horenstein A.L.; Stirpe F.; Battelli M.G.; Malavasi F.
Cell interaction of the type 1 RIP Saporin
2008 V. Scicchitano; L. Polito; M. Bortolotti; A. Bolognesi; M.G. Battelli
Characterization of highly toxic type 2 ribosome-inactivating proteins from Adenia lanceolata and Adenia stenodactyla (Passifloraceae)
2007 Stirpe F.; Bolognesi A.; Bortolotti M.; Farini V.; Lubelli C.; Pelosi E.; Polito L.; Dozza B.; Strocchi P.; Chambery A.; Parente A.; Barbieri L.
Chronic kidney disease: Which role for xanthine oxidoreductase activity and products?
2022 Polito L.; Bortolotti M.; Battelli M.G.; Bolognesi A.
Crystallization and preliminary X-ray diffraction data analysis of stenodactylin, a highly toxic type 2 ribosome-inactivating protein from Adenia stenodactyla.
2010 Tosi G.; Fermani S.; Falini G.; Polito L.; Bortolotti M.; Bolognesi A.
Distribution of RIP activity in tissue extracts from Fragaria x ananassa (strawberry) and its correlation with environmental stress
2008 Bortolotti M.; Polito L.; Chatgilialoglu A.;Mancuso R.; Baruzzi G.; Faedi W.; Bolognesi A.
Due nuove tossine per la chemoablazione sperimentale nello strabismo e nei disordini del movimento (blefarospasmo).
2006 Fiorini C.; Bortolotti M.; Polito L.; Bolognesi A.
Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling
2020 Mercatelli D.; Bortolotti M.; Andresen V.; Sulen A.; Polito L.; Gjertsen B.T.; Bolognesi A.
Endocitosi e traffico intracellulare della Saporina-S6
2008 V. Scicchitano; L. Polito; M. Bortolotti; M.G. Battelli
Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6
2012 Bolognesi A.; Polito L.; Scicchitano V.; Orrico C.; Pasquinelli G.; Musiani S.; Santi S.; Riccio M.; Bortolotti M.; Battelli MG.
Epratuzumab/Saporin-S6: an anti-CD22 immunotoxin for selective depletion of B-cells neoplasms
2010 Bortolotti M.; Polito L.; Farini V.; Bolognesi A.
Epratuzumab/saporina-S6: una immunotossina anti-CD22 per la deplezione delle cellule B linfomatose
2005 Farini V.; Polito L.; Lubelli C.; Bortolotti M.; Bolognesi A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| (ClO4)2: Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity | Toniolo, Gianluca; Louka, Maria; Menounou, Georgia; Fantoni, Nicolò Zuin; Mitrikas, George; Efthi...miadou, Eleni K.; Masi, Annalisa; Bortolotti, Massimo; Polito, Letizia; Bolognesi, Andrea; Kellett, Andrew; Ferreri, Carla; Chatgilialoglu, Chryssostomos | 2018-01-01 | ACS OMEGA | - | 1.01 Articolo in rivista | ACS 2018.pdf |
| A new potent and selective anti-lymphocytes-immunotoxin for the treatment of GVHD and lymphocyte-derived neoplasms | Polito L.; Bortolotti M.; Pedrazzi M.; Farini V.; Bolognesi A. | 2009-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering? | Zanello A.; Bortolotti M.; Maiello S.; Bolognesi A.; Polito L. | 2022-01-01 | FRONTIERS IN PHARMACOLOGY | - | 1.01 Articolo in rivista | 2022 FPhar-antiPD-L1.pdf |
| Anti-tumor activity of Epratuzumab/saporin-S6. | Bortolotti M.; Polito L; Farini V; Pedrazzi M; Battelli MG; Bolognesi A. | 2012-01-01 | THE AMERICAN JOURNAL OF PATHOLOGY | Elsevier | 4.02 Riassunto (Abstract) | - |
| Antibody conjugates for sarcoma therapy: How far along are we? | Polito L.; Calafato G.; Bortolotti M.; Chiarelli Olivari C.; Maiello S.; Bolognesi A. | 2021-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | 2021 biomedicines.pdf |
| Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1 | Polito, Letizia; Bortolotti, Massimo; Pedrazzi, Manuela; Mercatelli, Daniele; Battelli, Maria Giu...lia; Bolognesi, Andrea | 2016-01-01 | PHYTOMEDICINE | - | 1.01 Articolo in rivista | Phytomedicine.pdf |
| ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells. | Polito L.; Bortolotti M.; Farini V.; Pedrazzi M.; Tazzari P.L.; Bolognesi A. | 2009-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Bouganin, an attractive weapon for immunotoxins | bortolotti massimo; bolognesi andrea; polito letizia | 2018-01-01 | TOXINS | - | 1.01 Articolo in rivista | 2018 Toxins.pdf |
| CD38 as a target of IB4 mAb carrying saporin-S6: Design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia | Bolognesi A.; Polito L.; Farini V.; Bortolotti M.; Tazzari P.L.; Ratta M.; Ravaioli A.; Horenstei...n A.L.; Stirpe F.; Battelli M.G.; Malavasi F. | 2005-01-01 | JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS | - | 1.01 Articolo in rivista | - |
| Cell interaction of the type 1 RIP Saporin | V. Scicchitano; L. Polito; M. Bortolotti; A. Bolognesi; M.G. Battelli | 2008-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Characterization of highly toxic type 2 ribosome-inactivating proteins from Adenia lanceolata and Adenia stenodactyla (Passifloraceae) | Stirpe F.; Bolognesi A.; Bortolotti M.; Farini V.; Lubelli C.; Pelosi E.; Polito L.; Dozza B.; St...rocchi P.; Chambery A.; Parente A.; Barbieri L. | 2007-01-01 | TOXICON | - | 1.01 Articolo in rivista | - |
| Chronic kidney disease: Which role for xanthine oxidoreductase activity and products? | Polito L.; Bortolotti M.; Battelli M.G.; Bolognesi A. | 2022-01-01 | PHARMACOLOGICAL RESEARCH | - | 1.01 Articolo in rivista | 2022 Pharmacol Res.pdf |
| Crystallization and preliminary X-ray diffraction data analysis of stenodactylin, a highly toxic type 2 ribosome-inactivating protein from Adenia stenodactyla. | Tosi G.; Fermani S.; Falini G.; Polito L.; Bortolotti M.; Bolognesi A. | 2010-01-01 | ACTA CRYSTALLOGRAPHICA. SECTION F, STRUCTURAL BIOLOGY AND CRYSTALLIZATION COMMUNICATIONS | - | 1.01 Articolo in rivista | - |
| Distribution of RIP activity in tissue extracts from Fragaria x ananassa (strawberry) and its correlation with environmental stress | Bortolotti M.; Polito L.; Chatgilialoglu A.;Mancuso R.; Baruzzi G.; Faedi W.; Bolognesi A. | 2008-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Due nuove tossine per la chemoablazione sperimentale nello strabismo e nei disordini del movimento (blefarospasmo). | Fiorini C.; Bortolotti M.; Polito L.; Bolognesi A. | 2006-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling | Mercatelli D.; Bortolotti M.; Andresen V.; Sulen A.; Polito L.; Gjertsen B.T.; Bolognesi A. | 2020-01-01 | FRONTIERS IN PHARMACOLOGY | - | 1.01 Articolo in rivista | 2020 FPhar.pdf |
| Endocitosi e traffico intracellulare della Saporina-S6 | V. Scicchitano; L. Polito; M. Bortolotti; M.G. Battelli | 2008-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6 | Bolognesi A.; Polito L.; Scicchitano V.; Orrico C.; Pasquinelli G.; Musiani S.; Santi S.; Riccio ...M.; Bortolotti M.; Battelli MG. | 2012-01-01 | JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS | - | 1.01 Articolo in rivista | - |
| Epratuzumab/Saporin-S6: an anti-CD22 immunotoxin for selective depletion of B-cells neoplasms | Bortolotti M.; Polito L.; Farini V.; Bolognesi A. | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Epratuzumab/saporina-S6: una immunotossina anti-CD22 per la deplezione delle cellule B linfomatose | Farini V.; Polito L.; Lubelli C.; Bortolotti M.; Bolognesi A. | 2005-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |